Trade SMTI stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Sanara MedTech Inc. (SMTI) is trading at US$35.07, up 0.26% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$316.53M. Over the past 52 weeks, SMTI has traded between US$16.05 and US$35.27. On Syfe you can trade SMTI with $0 commission and add it to your watchlist.
| Previous close | US$34.98 |
|---|---|
| Market cap | US$316.53M |
| P/E ratio | 73.72 |
| 52-week range | US$16.05 – US$35.27 |
| Volume | 271.14K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Sanara MedTech Inc.
Sanara MedTech, Inc. engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.
Year: 2020
--HC Wainwright Downgrades Sanara MedTech to Neutral From Buy, Adjusts PT to $35 From $36
Jul 30, 11:13 AM · MT Newswires
Sanara MedTech Inc. (SMTI) stock is trading at US$35.07, +0.26% from the previous close of US$34.98.
The market cap for Sanara MedTech Inc. (SMTI) stock is approximately US$316.53M.
The price-to-earnings ratio for Sanara MedTech Inc. (SMTI) is 73.72, based on the latest reported earnings.
The 52-week high for Sanara MedTech Inc. (SMTI) stock is US$35.27.
The 52-week low for Sanara MedTech Inc. (SMTI) stock is US$16.05.
Sanara MedTech Inc. (SMTI) does not currently pay a dividend.
Stay on top of SMTI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
